Revenue | ₹1.04Cr |
Net Profits | ₹0.48Cr |
Net Profit Margins | -46.15% |
Skybiotech Healthcare Limited’s revenue fell -61.05% since last year same period to ₹1.04Cr in the Q3 2025-2026. On a quarterly growth basis, Skybiotech Healthcare Limited has generated -46.94% fall in its revenue since last 3-months.
Skybiotech Healthcare Limited’s net profit fell -23.08% since last year same period to ₹0.48Cr in the Q3 2025-2026. On a quarterly growth basis, Skybiotech Healthcare Limited has generated -54.84% fall in its net profits since last 3-months.
Skybiotech Healthcare Limited’s net profit margin fell -215.98% since last year same period to -46.15% in the Q3 2025-2026. On a quarterly growth basis, Skybiotech Healthcare Limited has generated -191.81% fall in its net profit margins since last 3-months.
The revenue for Skybiotech Healthcare Limited in the Q3 results 2025 was ₹1.04Cr.
The net profit for Skybiotech Healthcare Limited in the Q3 results 2025 was ₹0.48Cr.
The net profit margin for Skybiotech Healthcare Limited in the Q3 results 2025 was -46.15%.
The revenue for Skybiotech Healthcare Limited in the Q3 results 2024 was ₹2.67Cr.
The net profit for Skybiotech Healthcare Limited in the Q3 results 2024 was ₹0.39Cr.
The net profit margin for Skybiotech Healthcare Limited in the Q3 results 2024 was -14.61%.